Posts Tagged ‘Diagnostics’

Carl Zeiss Meditec Taps Mazzo To Lead Consolidated Unit

OIS board member Jim Mazzo joins Carl Zeiss Meditec

Carl Zeiss Meditec has moved to consolidate its diagnostic and surgical products in ophthalmology and has brought in well-known ophthalmology industry veteran, James V. Mazzo, to head up the new unit. Mazzo joins CZM as Global President of the ophthalmology unit with responsibility for the new strategic business unit along with overseeing CZM’s US sales…

Read More

Zeiss CEO Monz on Building a Really Strong Brand

Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG, shares how his company’s long history in ophthalmology helps it pave a path for new markets and technologies. Video Highlights 00:34 – How much of Carl Zeiss is ophthalmology? 01:00 – In ophthalmology we try to provide everything needed for diagnosis and treatment. 01:30…

Read More

Heidelberg Makes Move into Cataract-Refractive Field

Heidelberg Engineering, which has more than 10,000 optical coherence tomography (OCT) units in place worldwide, is looking to help drive the premium channel by entering the cataract-refractive field with swept-source OCT imaging, Managing Director Kester Nahen, PhD, reported at OIS@ASCRS 2016. Heidelberg Engineering previewed its cataract and refractive imaging platform last year at the European…

Read More

Diagnostics Here to Stay

A panel of physicians and corporate leaders discuss the increasingly important impact diagnostics have on the premium channel. Topics included number of tests done, appetite of investors and interest of corporate partners. Video Highlights 00:20 How important are preoperative diagnostics in managing the premium channel. 00:29 – Jay Pepose, MD, PhD, It’s very important. If…

Read More

Diagnostics on the Rise

Richard Lindstrom, MD, opened up the Diagnostics-Impact on the Premium Channel with an overview of the market including a look at competitors. Video Highlights 00:37 – Global revenues in diagnostics continue to grow. 00:55 – There are 700 diagnostic products and 85 manufacturers. 01:35 – Investment in funding imaging, OCT, optical biometry and operating microscopes.…

Read More

CZM Focuses on “A Lot of Little Things” to Move Premium Channel

Moving cataract surgery outcomes from 80% of patients within 0.5 D of targeted refraction to 95% requires “a lot of little things,” Karlheinz Rein, PhD, vice president of cataract and retina surgery at Carl Zeiss Meditec, said during the panel on diagnostics and the premium channel at OIS@ASCRS 2016. The increased use of optical coherence…

Read More

LacriScience Enters Next Chapter

Chris D. Geddes, Ph.D, and Paul Gavaris of LacriScience share the prototype of the LacriPen, a handheld, portable, diagnostic tool that measures osmolarity to within 2 mOsml and can detect other viruses and bacteria including Methicillin-resistant Staphylococcus aureus (MRSA). Highlights 00:24 – “This has been a pivotal moment.” 00:53 – “We’ve had a lot of traction…

Read More

TearScience Pivots to Focus on Early-Stage OSD

TearScience, the device company focused on the role of the meibomian glands in dry eye, has pivoted its business model to concentrate more on early-stage meibomian gland dysfunction (MGD) with the LipiFlow thermal pulsation device and high-definition imaging of the meibomian glands, President and CEO Joseph Boorady, OD, told OIS@ASCRS 2016. Dr. Boorady himself is…

Read More

TearLab Targets Multiple Biomarkers in Dry Eye

A physiologically stable ocular surface is a big determinant in cataract and refractive surgery outcomes, so TearLab Corp. is looking to build out its lab-on-a-chip platform to evaluate the ocular surface for additional biomarkers, CEO Seph Jensen told the panel on diagnostics and the premium channel at OIS@ASCRS 2016. The TearLab Osmolarity Test, for diagnosing…

Read More

Cassini Bets on Total Corneal Analysis to Drive Premium Channel

The key to growing the toric intraocular lens (IOL) sector for cataract surgery lies in obtaining more accurate measures of total corneal astigmatism, and Cassini thinks it has that key in its novel total corneal analysis (TCA), Chief Medical Officer Mark Packer, MD, said at OIS@ASCRS 2016. Cassini uses patented, colored, LED ray-tracing technology to…

Read More

What the Heck Happened at OIS@ASCRS? – OIS Podcasts Hit Some Highlights from Last Week’s Stellar Meeting in New Orleans

What the Heck Happened at OIS@ASCRS? OIS Podcasts Hit Some Highlights from Last Week’s Stellar Meeting in New Orleans - OIS Podcast

The fifth OIS@ASCRS delivered highlights on diagnostics, glaucoma devices, and What The Future of ophthalmology might bring. OIS Podcasts will provide a quick review of the day for those who couldn’t make it (or simply had overstuffed their meeting calendar in New Orleans). Tom Salemi: Hi, Everyone, welcome back to the OIS Podcast. We are…

Read More